Risk factors

Immucell (ICCC) risk factors

Item 1A of every Immucell Corp. 10-K on file, and what changed from one year to the next.

Open ICCC in Gloomberb →
  • FY2025 10-K risk factors

    36 risks, 6 new, 12 dropped, 19 reworded since the prior year. Re-Tain® strategy shifted from internal manufacture toward licensing, sale, or partnership after abandoning planned production.

    Filed Mar 30, 2026
  • FY2024 10-K risk factors

    42 risks. Re-Tain® commercialization depends on FDA approval, funding, customer adoption, and reliable contract manufacturing.

    Filed Mar 28, 2025